Search
Gadoxetic acid Metabolism
smpdb.ca/view/SMP0126873MetabolicGadoxetic acid is a gadolinium-based contrast agent used in magnetic resonance imaging (MRI) to help characterize lesions in the liver. … The water protons in the vicinity are disrupted such that the change the proton density and spin characteristics are detected and visualized by a device.
Drugs: Gadoxetic acidTranexamic Acid Action Pathway
smpdb.ca/view/SMP0000287Drug actionTranexamic acid is a synthetic version of an amino acid found in the body called lysine that plays a role in antifibrinolytic processes. It is used to stop bleeding and hemorrhaging in patients. … Tranexamic acid inhibits plasminogen.
Gamma-Aminobutyric Acid Biosynthesis
smpdb.ca/view/SMP0125090MetabolicGABA is transported into a synaptic vesicle by Vesicular inhibitory amino acid transporter. The vesicle is activated by calcium entering the presynapse as well as cAMP. … Glutamate is catalyzed in the neuron with the enzyme Glutamate decarboxylase-1 to synthesize GABA and a byproduct of carbon dioxide.
Drugs: Pyridoxal phosphate · Glutamic acid · ATP · Calcium · Magnesium cation · Cyclic adenosine monophosphate +2 moreEnzymes: Voltage-dependent P/Q-type calcium channel subunit alpha-1A, Vesicular inhibitory amino acid transporterLysophosphatidic Acid LPA1 Signalling
smpdb.ca/view/SMP0063746SignalingLysophosphatidic acid (LPA) is a water-soluble phospholipid derivative and a potent signalling molecule that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6. … Both calcium and DAG activate the kinase activity of protein kinase C beta (PKC). Among many other functions, PKC activates NF-κB.
Enzymes: Lysophosphatidic acid receptor 1Lysophosphatidic Acid LPA3 Signalling
smpdb.ca/view/SMP0063755SignalingLysophosphatidic acid (LPA) is a water-soluble phospholipid derivative and a potent signalling molecule that binds to six known lysophosphatidic acid receptors (LPARs), named LPA1-LPA6. … Both calcium and DAG activate the kinase activity of protein kinase C beta (PKC). Among many other functions, PKC activates NF-κB.
Enzymes: Lysophosphatidic acid receptor 3Tolfenamic acid Action Pathway
smpdb.ca/view/SMP0126549Drug actionThe inhibition of both COX-1 and COX-2 by tolfenamic acid reduces the formation of prostaglandin H2 and therefore, prostaglandin E2 (PGE2). … The low concentration of prostaglandin E2 attenuates the effect it has on stimulating immune cells and pain fibers, consequently reducing inflammation and pain.
Acetohydroxamic acid Drug Metabolism
smpdb.ca/view/SMP0130492MetabolicAcetohydroxamic acid passes through the liver and is then excreted from the body mainly through the kidney. … Acetohydroxamic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Acetohydroxamic acidAcetic acid Drug Metabolism
smpdb.ca/view/SMP0130504MetabolicAcetic acid passes through the liver and is then excreted from the body mainly through the kidney. … Acetic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Acetic acidEtidronic acid Drug Metabolism
smpdb.ca/view/SMP0130677MetabolicEtidronic acid passes through the liver and is then excreted from the body mainly through the kidney. … Etidronic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Etidronic acidMedronic acid Drug Metabolism
smpdb.ca/view/SMP0130690MetabolicMedronic acid passes through the liver and is then excreted from the body mainly through the kidney. … Medronic acid is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.
Drugs: Medronic acid